Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Chinese Journal of Cancer|May 13, 2015
Cytokine-induced killer (CIK) cells: from basic research to clinical translationYelei Guo, Weidong HanJournal of Immunology Research|March 22, 2016
Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and ProspectsYelei Guo, Yao Wang, Weidong HanProtein & Cell|May 4, 2017
Current status and perspectives of chimeric antigen receptor modified T cells for cancer treatmentZhenguang Wang, Yelei Guo, Weidong HanProtein & Cell|March 15, 2017
Targeting cancer stem cells by using chimeric antigen receptor-modified T cells: a potential and curable approach for cancer treatmentYelei Guo, Kaichao Feng, Yao Wang, et al.Central-European Journal of Immunology|December 10, 2015
Staphylococcus enterotoxin B-induced T cells can efficaciously protect against type 1 diabetes in non-obese diabetic miceYelei Guo, Lei Xia, Shilun Zhang, et al.Cytotherapy|August 14, 2018
Restoration of CD3<sup>+</sup>CD56<sup>+</sup> cell level improves skin lesions in severe psoriasis: A pilot clinical study of adoptive immunotherapy for patients with psoriasis using autologous cytokine-induced killer cellsHanren Dai, Yong Zhou, Chuan Tong, et al.Science China. Life Sciences|March 13, 2016
Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancerKaichao Feng, Yelei Guo, Hanren Dai, et al.Molecular Cancer Therapeutics|January 18, 2026
MCT1 inhibition remodels the tumor immune microenvironment for enhanced cancer immunotherapyYipeng Zhang, Chun Liu, Fuxin Han, et al.Scientific Reports|July 2, 2015
Beta-cell regeneration from vimentin+/MafB+ cells after STZ-induced extreme beta-cell ablationYu Cheng, Hongjun Kang, Jing Shen, et al.Cellular & Molecular Immunology|October 1, 2020
Clinical development of CAR T cell therapy in China: 2020 updateJianshu Wei, Yelei Guo, Yao Wang, et al.Pageof 4